Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy' JOHN A. SIMPSON From the Department of Medicine, Edinburgh University, and the ANeurological Unit, Northern General Hospital, Edinburgh
During the years 1953-55 I was privileged to examine a large number of patients who had been treated for myasthenia gravis at the National Hospital and other centres in London. The survey was made in order to evaluate the efficacy of thymectomy in the treatment of that disease. In reviewing the results it was remarked that myasthenia gravis was a favourite subject for the demonstration of the physiological mechanisms in disease yet, despite a period of unprecedented advances in knowledge of the physiology of the neuromuscular junction, the nature of the myasthenic response remained unknown. None of the theories current at that time attempted to account for the facts of thymic pathology and of clinical response to thymectomy. The role of surgery was indeed still debated, but the review showed that there was a statistically significant benefit to a myasthenic patient provided that the thymus was removed within five years of the onset of symptoms (Simpson, 1958) . This temporal limitation is difficult to account for if the thymus is producing a 'curare-like' substance as ordinarily understood.
It was decided to approach the problem without bias by recording as fully as possible the medical history of each patient interviewed. No (1960) as the Honyman-Gillespie lecturer is forbidden to discuss animal experiments.) Nevertheless the concept seemed to account for more details of the disease than any hitherto available though it involved the assumption that the thymus did not function as an endocrine gland in the usual sense but as a reticuloendothelial organ which was important in immunity reactions, probably the first suggestion of this role. During the next three years the concept of autoimmunity as a mechanism in disease was gaining ground. My conviction that it was a factor in myasthenia gravis was increased when in 1959 Smithers remarked that the histological changes in the thymus were suggestive of an autoimmune process and Nastuk, Strauss, and Osserman (1959) , while searching for a neuromuscular blocking substance, found that blood from myasthenic patients sometimes caused lysis of frog muscle cells. A lesser degree of cytolysis was caused by blood from some normal subjects. They then examined the activity of serum complement. In most myasthenic patients it was within the normal range but in a few cases it was either high or far below normal and this tended to correlate with remissions and exacerbations respectively (Nastuk, Plescia, and Ossernian, 1960) . 485 Though Smithers (1959) did not suggest how the muscle disease could be caused and the American team did not consider a role for the thymus, their independent evidence encouraged me to formulate a hypothesis which was described in a HonymanGillespie lecture in April 1960. It was suggested that the thymus might stimulate the production of lymphocytes carrying antibody against the endplate protein of muscle, and possibly also against muscle fibres, nerve endings, and on occasion the central nervous system and other organs such as the bone marrow and thejoints, in close analogy with systemic lupus erythematosus. It was shown that an antibody could act as a neuromuscular blocking substance of 'competitive' type which would account for the myasthenic phenomenon. (The American cytolytic theory does not explain the reversible nature of the weakness.) Furthermore, an antibody against muscle could account for the facts that a baby born to a myasthenic mother may have temporary myasthenia, yet transfusion of blood from a myasthenic patient into another adult does not cause myasthenic signs. Coincident with the publication of this lecture (Simpson, 1960) , Strauss, Seegal, Hsu, Burkholder, Nastuk, and Osserman (1960) demonstrated the presence of a muscle-binding globulin in myasthenic serum and this has been confirmed by Beutner, Witebsky, Ricken, and Adler (1962) and Feltkamp, van der Geld, and Oosterhuis (1963b) . These authors describe four different types of reaction of globulin to muscle based on immunofluorescence techniques: (1) fluorescence of the sarcolemma, which also occurs with control sera; (2) fluorescence of the A bands of muscle fibres; (3) similar involvement of only about half of the muscle fibres ('zebra' type); and (4) nuclear fluorescence. Only types (2) and (3) seem to be specific for myasthenia gravis.
There is not at present any direct evidence for an antibody confined to the endplate zone such as I had postulated, nor to the nerve terminals which was suggested as an alternative. A further search should be made for these as the present evidence suggests that the antibodies against the muscle fibres only occur in significant quantity in the presence of a thymic tumour (vide infra). The nuclear fluorescence is due to the presence of antinuclear factor in the serum (Feltkamp, van der Geld, Kruyff, and Oosterhuis, 1963a) .
The response to the autoimmune hypothesis was immediate. Marshall and White (1961) showed that direct injection of bacterial antigen into the guineapig thymus produced a histological reaction which was essentially the same as that seen in myasthenia gravis. Their studies suggested that a blood-thymus barrier exists which would preclude any cellular reaction of the normal thymus to circulating antigen and so facilitate the development of immunologically competent cells active even against an individual's own tissues. By this time experimental biologists were coming to the conclusion that the thymus played a very important role in the development of immunological response (Miller, 1961 (Miller, , 1963 Burnet, 1962a, b) . It seems very likely that immunological mechanisms are disturbed in myasthenia gravis. It remains to be demonstrated whether they are causative or not.
One question which immediately arises is whether the immunological response is organ and speciesspecific. The cytolytic effect described by Nastuk et al. (1959) on frog muscle, and the globulinbinding on human and rat skeletal muscle (Strauss et al., 1960; Feltkamp et al., 1963a, b) demonstrate that the antibodies are not species-specific. Strauss et al. (1960) found that the globulin which binds to skeletal muscle does not do so with cardiac or uterine muscle and they also had negative results against thymus tissue obtained from two myasthenic patients. The reaction was shown to cause fixation of complement. Their positive results were obtained from the pooled sera of 10 myasthenic patients, of whom six had a thymoma. Many others investigated showed no muscle-binding globulin in their serum. Beutner et al. (1962) confirmed their results with sera from two of 10 myasthenic patients. Both sera, which were obtained from the only cases with a thymoma, also showed fluorescence with heart muscle by the direct and indirect fluorescent antibody techniques, but the complement-fixing and staining technique using heart tissue was negative. The presence of at least two antibodies is suggested, one specific to skeletal muscle and the other reacting with skeletal and cardiac muscle. Van der Geld and Oosterhuis (1963) , using an antiglobulin consumption test with or without the aid of immunoelectrophoresis, found that 40% of sera containing antibodies reacting with skeletal muscle also reacted with thymus. They did not encounter sera with antibodies acting exclusively against thymus. Crossabsorption experiments suggested that there were two distinct circulating antibodies, one of which reacted with skeletal muscle or thymus, the other with skeletal muscle alone. No reaction was found with heart, liver, pancreas, or kidney tissues. The incidence of anti-muscle antibodies was consistently higher in cases with thymoma (van der Geld, Feltkamp, Loghem, Oosterhuis, and Biemond, 1963) and this may account for our failure to find convincing evidence of anti-muscle antibodies since there were no patients with thymoma in the small series investigated. It would be interesting to examine the correlation between muscle antibodies of the Strauss type and the atrophic muscular weakness found in Immyiiunnological dlistuirbances in miiyasthenia gravis with a report of Hashinioto's lisease some myasthenics which does not respond to anticholinesterase drugs. This 'myasthenic myopathy' was not a feature of the cases I examined for muscle antibodies. It is more common in cases associated with a thymoma though not confined to them (Simpson, 1958) . Burnet (1962b) classified myasthenia gravis in his group I (organ-specific) type of autoimmune disease while acknowledging that a possible relationship with rheumatoid arthritis might necessitate revision of this provisional classification. This putative relationship was based on the present author's paper (see Burnet, 1962a ). In the original report (Simpson, 1960 ) the disorder was listed as 'rheumatoid' arthritis to indicate that it resembled true rheumatoid arthritis but might differ from it. This was done because the arthropathy affected the small joints ( Fig. 1) but was sometimes transitory. Van der Geld et al. (1963) have recently reported that the rheumatoid factor was present in the serum of five of 111 (4 5%) cases of myasthenia gravis (Tables I and Il) . Six patients in their series had rheumatoid arthritis (sic), but it seems from a letter by Feltkamp et al. (1963a) that only one of these patients had the rheumatoid factor in the blood so it would appear that the other positive findings were Marshall (1962) , and two of these had a positive nuclear fluorescence with undiluted serum. Thyroid latex test for rheumatoid factor and hyperglobu-tissue was used to detect the presence of antinuclear linaemia at the time of examination or previously. factor in the serum. The positive reactors included Alexander, Bremner, and Duthie (1960) who found 4% positives in 580 controls (healthy young blood donors of both sexes). The cases relevant to the present paper are summarized in Table  111 .
The original series (Simpson, 1960) contained one case of pure red-cell aplasia. Holborow, Asherson, Johnson, Barnes, and Carmichael (1963) report a positive antinuclear factor test in a case of this disorder associated with a thymoma. There were four cases of pernicious anaemia in the earlier report and this has now increased to nine (Table I ) Red-cell aplasia has been associated with myasthenia gravis and thymomas by several authors but no correlation has been described between myasthenia gravis and pernicious anaemia though it has been mentioned in one report (Rowland, Hoefer, Aranow, and Merritt, 1956) . My own cases are described in another paper (in preparation). It has recently been suggested that pernicious anaemia is associated with an immunological disorder with production of organspecific antibody to intrinsic factor and to the parietal cells of the stomach (Schwartz, 1960; Irvine, Davies, Delamore, and Williams, Wynn 1962; Taylor, Roitt, Doniach, Couchman, and Shapland, 1962) . In the present series of myasthenic patients, antibody active against human stomach was detected in three of 35 (Irvine, 1964) . The other patients with pernicious anaemia listed in the full series (Table I) are no longer available for immunological studies. It has also been reported recently that pernicious anaemia may be associated with rheumatoid arthritis (Partridge and Duthie, 1963) , with autoimmune thyroiditis (Irvine et al., 1962; Taylor et al., 1962; Markson and Moore, 1962) , with thyrotoxicosis and systemic lupus erythematosus (Doniach, Roitt, and Taylor, 1963) , and with diabetes mellitus (Arapakis, Bock, Williams, and Witts, 1963; Beckett and Matthews, 1962) . There is thus an overlap between several diseases associated with abnormal immunological reactions and to these myasthenia gravis should now be added. The relationship between thyrotoxicosis and myasthenia gravis has been known for many years but Simpson (1960) showed that the relationship was indirect and could be genetic. Many of the cases previously described have shown diffuse lymphoid changes in the thyroid. Case MN 5503 (Table III) was found to have thyroiditis of Hashimoto type at necropsy. This was unsuspected during life until thyroid antibodies were found in her blood. One case of myasthenia with thymoma had Hashimoto's struma (not included in the Table) (Fig. 2) From 1960 he complained at intervals of abdominal pain, sweating, and tiredness, which were alleviated by regulation of the dosage of neostigmine and pyridostigmine. During one such episode he was admitted to Inverness Royal Infirmary where it was noted that he had a diffuse goitre and pigmentation. of the face (Fig. 3) . He was complaining of tiredness and dyspnoea which were not improved by regulation of dosage and were not apparently due to reactivation of tuberculosis. He was overweight and showed no clinical evidence of thyrotoxicosis.
A radio-iodine uptake test gave a T.P.I. of 1-6 and the protein-bound iodine was 1-4 mg. per 100 ml. Serum cholesterol concentration was 200 mg. per 100 ml. Antibody titres against thyroid tissue were T.C.H. 1/2,500,000; C.F. Thyroid antibodies have been present in 10 of 38 cases examined in this series by the method described by Irvine (1964) . Six of the positive reactors have had confirmed or suspected thyrotoxicosis at some time in the past and another four cases with a similar history have not had a significant level of antithyroid substances in their serum. The others shown in Table III have not been examined for thyroid antibodies. Van der Geld et al. (1963) (Forbes, 1947) . Ulcerative colitis and hepatic cirrhosis were associated with systemic lupus erythematosus which followed thymectomy for myasthenia gravis in a patient recently reported by Alareon-Segovia, Galbraith, Maldonado, and Howard (1963 
DISCIJSSION
The es idence gathered together in this paper supports the hypothesis that myasthenia gravis is associated with disturbed antigen-antibody reactions but demonstrates that there may be several organ-specific antibodies present and that there is a clinical and serological overlap with many other autoimmune disorders. Antibodies against muscle fibres are rare except in the presence of a thymic tumour and may not account for the defect of neuromuscular transmission. Some of the permanent weakness found in severe myasthenia, notably in association with a thymoma, may be due to this type of reaction. The possibility of a more localized end-plate reaction remains unconfirmed. The multiplicity of antibodies m-akes it unlikely that each organ is 'leaking' antigen which then 'instructs' the reticuloendothelial system to form appropriate antibody. It is more probable that the antibody-producing mechanism is producing proteins of which some react with various tissues. There can now be little doubt that the thymus plays a key role in the regulation of antibody production at least in foetal life but the persistence of myasthenia after thymectomy or the development after thymectomy of myasthenia gravis (Green and Booth, 1958) , thyrotoxicosis (personal experience), ulcerative colitis, and systemic lupus erythematosus (AlarconSegovia et al., 1963) make it certain that the thymus is not necessary for the continuation of the disease or for the subsequent development of autoimmune disorders. The present paper records a case of Hashimoto's disease which probably occurred at least five years after thymectomy.
The observation that thymectomy is most beneficial if performed within five to seven years of the onset of myasthenia gravis might imply that it is an essential element at first but that other parts of the reticuloendothelial system may then continue to produce autoantibodies without its presence (Simpson, 1958 (Simpson, , 1960 . Nothing is known of the nature of the possible changes of immunological tolerance. Burnet (1962a) discusses various hypotheses involving failure of a homoeostatic control of the thymus and White and Marshall (1962) suggest a breakdown of a blood-thymus barrier. Since the first part of the writer's hypothesis has proved so acceptable it might not be inappropriate to draw attention to the other part. A study of the personal and family histories of 440 patients with myasthenia gravis suggested that the altered immunological tolerance might be due to a genetic factor acting on the thymus through the pituitary gland. This may provide the intrinsic (nonimmunological) stimulus to the thymus or the homoeostatic mechanism required by Burnet's theory. Burnet (1962a) proposes that the thymus is primarily concerned with the maintenance of the chemical integrity of the body, including the mechanism of specific protein synthesis. He suggests that the development of the immunological competence of the body is part of the process of morphological and functional differentiation of the embryo and young animal as previously postulated by Simpson (1960) . Weiss (1950) and Burwell (1963) 
SUMMARY
The author's hypothesis of an autoimmune mechanism in myasthenia gravis is summarized and further evidence reviewed. A high incidence of thyroid disorders, pernicious anaemia, and a rheumatoid type of arthritis is reported. Many cases had antinuclear factor and others had antibodies in their serum specific against thyroid or gastric tissue. No significant antimuscular activity was found in a small sample and it is suggested that this disagreement with other workers is due to absence of thymoma in the cases examined. The occurrence of Hashimoto's disease in a myasthenic patient is recorded. This is the first report of the association and also of the occurrence ofHashimoto's disease in a patient without a thymus. A hormonal homoeostatic mechanism for the thymus is suggested.
